$1,000 invested Bristol-Myers Squibb (2016)
NYSE · BMY · reinvest dividends · adjusted close
●Result2016-01-04 — 2026-08-28
Today you would have
$1,413
+$413 (+41.28%)
BMYSPY (benchmark)
- Entry price
- $47.13
- Current price
- $66.58
- Shares
- 21.2196
- CAGR
- +3.30%
- Max Drawdown
- -47.67%
- vs SPY
- -311.52 pp
✦The story
A $1,000 stake in Bristol-Myers Squibb from January 2016 grew to just $1,413 by mid-2026, a total return of +41.3%. Despite major moves such as the acquisition of Celgene in 2019, the stock delivered only modest gains over the decade. The S&P 500 returned +352.8% over the same period.
#Related scenariosfor comparison
Other years for BMY